FRACTYL HEALTH, INC.

Fractyl Health, Inc.

Biotechnology • Healthcare • Burlington, MA, United States • GUTS (NGM)

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

781 902 8800 3 Van de Graaff Drive, Burlington, MA 01803, United States

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Watkins Advises on Fractyl Health’s US$60 Million Underwritten Offering of Common Stock - Latham & Watkins LLP
Latham & Watkins LLP • Sep 26
With 58% institutional ownership, Fractyl Health, Inc. (NASDAQ:GUTS) is a favorite amongst the big guns - Yahoo Finance
Yahoo Finance • Dec 18
Is Fractyl Health Poised for a Bounce? - StocksToTrade
StocksToTrade • Nov 17
What's Going On With Fractyl Health Stock Tuesday? - Fractyl Health (NASDAQ:GUTS) - Benzinga
Benzinga • Dec 2
Canaccord Genuity reiterates Buy rating on Fractyl Health stock - Investing.com
Investing.com • Dec 19

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has FRACTYL HEALTH, INC. had layoffs?
No layoff events have been recorded for FRACTYL HEALTH, INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does FRACTYL HEALTH, INC. have?
FRACTYL HEALTH, INC. has approximately 101 employees.
What industry is FRACTYL HEALTH, INC. in?
FRACTYL HEALTH, INC. operates in the Biotechnology industry, within the Healthcare sector.
Is FRACTYL HEALTH, INC. a publicly traded company?
Yes, FRACTYL HEALTH, INC. is publicly traded under the ticker symbol GUTS on the NGM. The company has a market capitalization of approximately $0.31 billion.
Where is FRACTYL HEALTH, INC. headquartered?
FRACTYL HEALTH, INC. is headquartered in Burlington, MA, United States at 3 Van de Graaff Drive, Burlington, MA 01803, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.